Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -5.49% is 62% above its 5-year average of -14.60%, near the high end of its 5-year range (-446.71%–50.59%).
54.37% above its 12-month average of -12.03%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11.04%.
NET PROFIT MARGIN
-5.49%
NET PROFIT MARGIN AVG TTM
-12.03%
NET PROFIT MARGIN AVG 3Y
-23.12%
NET PROFIT MARGIN AVG 5Y
-14.60%
NET PROFIT MARGIN AVG 10Y
-4.55%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
+54.37%
CURRENT VS 3Y AVG
+76.25%
CURRENT VS 5Y AVG
+62.40%
CURRENT VS 10Y AVG
-20.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 582 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Fennec Pharmaceuticals Inc.
Market Cap
$354.49M
Net Profit Margin
-5.49%
TTM Avg
-12.03%
3Y Avg
-23.12%
5Y Avg
-14.60%
Market Cap
$352.12M
Net Profit Margin
8.59%
TTM Avg
7.90%
3Y Avg
10.47%
5Y Avg
19.48%
Market Cap
$352.03M
Net Profit Margin
-96.89%
TTM Avg
-148.47%
3Y Avg
-151.80%
5Y Avg
-119.69%
Market Cap
$350.08M
Net Profit Margin
-1091.82%
TTM Avg
-436.37%
3Y Avg
-220.06%
5Y Avg
-1750.93%
Market Cap
$342.23M
Net Profit Margin
0.00%
TTM Avg
-11651.99%
3Y Avg
-6142.69%
5Y Avg
-4693.07%
Market Cap
$371.12M
Net Profit Margin
-81.04%
TTM Avg
-157.37%
3Y Avg
-379.90%
5Y Avg
-317.33%
Market Cap
$338.34M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$376.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$333.48M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $354.49M | -5.49% | -12.03% | -23.12% | -14.60% |
| Embecta Corp. (EMBC)vs › | $352.12M | 8.59% | 7.90% | 10.47% | 19.48% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $352.03M | -96.89% | -148.47% | -151.80% | -119.69% |
| Opus Genetics, Inc. (IRD)vs › | $350.08M | -1091.82% | -436.37% | -220.06% | -1750.93% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $342.23M | 0.00% | -11651.99% | -6142.69% | -4693.07% |
| Canopy Growth Corporation (CGC)vs › | $371.12M | -81.04% | -157.37% | -379.90% | -317.33% |
| Agenus Inc. (AGEN)vs › | $338.34M | 69.34% | -109.76% | -150.31% | -135.75% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $376.93M | 0.00% | 0.00% | -102.82% | -175.43% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.48M | -81.76% | -64.66% | -75.38% | -73.80% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.28M | -391.90% | -78.17% | -42.66% | -429.16% |
Operating Margin
-14.2%
Net Profit Margin
-5.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 11.04% |
| 2026-03-31 | 1.33% |
| 2025-12-31 | -34.75% |
| 2025-09-30 | -5.12% |
| 2025-06-30 | -32.66% |
| 2025-03-31 | -13.31% |
| 2024-12-31 | -25.05% |
| 2024-09-30 | -82.23% |
| 2024-06-30 | -76.47% |
| 2024-03-31 | 50.59% |
| 2023-12-31 | -27.55% |
| 2023-09-30 | -28.66% |
| 2023-06-30 | -163.73% |
| 2023-03-31 | -360.88% |
| 2022-12-31 | -446.71% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -1904.71% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
